Topical corticosteroids (TCS), topical calcineurin inhibitors tacrolimus and pimeclimus, and the more recently developed phosphodiesterase 4 (PDE4) inhibitor creborol are some of the treatments for AD (Bieber, 2022). This evidence concerns the gene PDE4A and Alzheimer disease.